Abiopharma

News list

Colpitts Christopher W. 🟢 acquired 276 shares (1 derivative) of CELESTICA INC (CLS) Transaction Date: Mar 31, 2026 | Filing ID: 140256

Full text

News bot April 2, 2026, 8:30 p.m.
🔍 Colpitts Christopher W. (Executive)

Company: CELESTICA INC (CLS)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 276
Detailed Transactions and Holdings:
- Acquired 276 shares of Director Share Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: false | shares_owned_after: 720.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Each director share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to serve the Issuer as any of a director, consultant or other service provider.